Skip to content
Evolution of Renal Cell Cancer Treatments since 2010
How I Treat Metastatic Colon Cancer in 2023
How I Treat Metastatic Esophageal and Gastric Cancer in 2023
How I Use Liquid Biopsy for GI Cancers in 2023
How I treat HER2+ Breast Cancer in 2023
How I treat Triple Negative Breast Cancer in 2023
Local Advanced NSCLC Neoadjuvant/ Adjuvant Update
Metastatic Targeted Therapy Updates
Metastatic Lung Immunotherapy Updates
Project Optimus and Optimizing Dose and Schedule in Early Phase Clinical Trials
Novel Trial Designs for Early Phase Clinical Trials: Beyond 3+3
Translating Pre-Clinical Studies to NCI-CTEP Clinical Trials
Convergence of Liquid Biopsy and Precision Oncology in the Management of NSCLC
Advances in Non-PD(L)1 Immunotherapies
Advances in Car-T Cells Development for Cancer Therapy
Management of Immune Related Adverse Events
Pancreatic and Hepatobiliary Cancer: Emerging Strategies
Colorectal Cancer: State of the Art
Advances in Esophageal and Gastric Cancer
Updates in Immunotherapy for Lung Cancer
Updates in Targeted Therapy for NSCLC
Advances in Small Cell Lung Cancer and Mesothelioma/Thymic Malignancies
Updates in Treatment of Early Stage and Locally Advanced NSCLC
The Future of Developmental Therapeutics in Oncology
Post navigation
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok 
